About S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo
L'Azienda ospedaliera Santi Antonio e Biagio e Cesare Arrigo è la principale struttura ospedaliera della città di Alessandria. Fondato nel 1567, nella classifica sui migliori ospedali stilata nel 2013 da Agenas il polo alessandrino occupa il terzo posto, dopo il San Raffaele di Milano e gli Spedali Civili di Brescia.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Gruppo Italiano Malattie EMatologiche dell'Adulto
28
Fondazione Italiana Linfomi ONLUS
9
Hoffmann-La Roche
5
Celgene
4
Northern Italy Leukemia Group
3
Fondazione Italiana Sindromi Mielodisplastiche-ETS
2
Incyte Corporation
1
Clinical Trials at S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo
During the past decade, S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 6 clinical trials were completed, i.e. on
average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 4 clinical trials were completed. i.e. 44.4%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Fludarabine and Alemtuzumab or Cyclophosphamide Followed by Peripheral Blood Stem Cell Transplant or Alemtuzumab in Treating Patients With Advanced or Progressive Chronic Lymphocytic Leukemia
2007-05-01
2011-06-01
Completed
86
A Remission Induction Therapy and Risk-oriented Postremission Strategy for Adult Acute Myelogenous Leukemia (AML)
2006-11-01
2015-12-01
Completed
573
Prednisone or Dexamethasone in Newly Diagnosed, Previously Untreated Primary Immune Thrombocytopenic Purpura
2008-04-01
2016-02-01
Completed
150
A Study to Evaluate the Efficacy of Lenalidomide as Maintenance Therapy After Completion of First-line Combination Chemotherapy in Patients With Mantle Cell Lymphoma (MCL).
2010-04-01
2011-03-01
Terminated
9
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Lower Risk Myelodysplastic Syndrome (MDS) Without Del 5q
2010-01-26
2018-05-09
Completed
239
A Study of MabThera (Rituximab) in Elderly Patients With Untreated Follicular Non-Hodgkin's Lymphoma (NHL)
2004-01-19
2011-07-21
Completed
234
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo" #1 sponsor was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 28 trials, followed by "Fondazione Italiana Linfomi ONLUS" with 9 trials
sponsored, "Hoffmann-La Roche" with 5 trials sponsored, "Celgene" with 4 trials sponsored and "Northern Italy Leukemia Group"
with 4 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo"
#1 collaborator was "AbbVie" with 1 trials as a collaborator, "ERIC Group" with 1 trials as a collaborator, "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator, "GRADE Onlus" with 1 trials as a collaborator and "Janssen-Cilag S.p.A." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo
According to Clinical.Site data, the most researched conditions in "S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo" are
"Acute Myeloid Leukemia" (4 trials), "Acute Promyelocytic Leukemia" (3 trials), "Chronic Lymphocytic Leukemia" (3 trials), "Chronic Myeloid Leukemia" (3 trials) and "Lymphoma" (3 trials). Many other conditions were trialed in "S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo" in a lesser frequency.
Clinical Trials Intervention Types at S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo
Most popular intervention types in "S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo" are "Drug" (37 trials), "Other" (9 trials), "Procedure" (3 trials), "Behavioral" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.
The name of intervention was led by "Rituximab" (6 trials), "Placebo" (4 trials), "Venetoclax" (4 trials), "Cyclophosphamide" (3 trials) and "Doxorubicin" (3 trials). Other intervention names were less common.
Clinical Trials Genders at S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo
The vast majority of trials in "S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo" are
51 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo
Currently, there are NaN active trials in "S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo".
1 are not yet recruiting,
11 are recruiting,
10 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 24 completed trials in S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo, 1 "Phase 1"
clinical trials were conducted, 18 "Phase 2" clinical
trials and 13 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".